![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00390975 |
This study will assess gastric emptying in patients with symptoms of diabetic gastroparesis treated with tegaserod over 2 weeks.
Condition | Intervention | Phase |
---|---|---|
Gastroparesis Diabetes |
Drug: Tegaserod |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Official Title: | An Open-Label Pilot Trial to Assess the Effect of Tegaserod on Improvement of Gastric Emptying in Patients With Diabetic Gastroparesis and Upper Gastrointestinal Symptoms |
Estimated Enrollment: | 40 |
Study Start Date: | January 2007 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
United States, Kansas | |
The University of Kansas Medical Center | |
Kansas City, Kansas, United States, 66160 | |
United States, Kentucky | |
The University of Louisville | |
Louisville, Kentucky, United States, 40292 | |
United States, Massachusetts | |
Beth Israel Deaconess Medical Center | |
Boston, Massachusetts, United States, 02215 |
Study Chair: | Novartis Pharmaceutical Corporation | NPC |
Study ID Numbers: | CHTF919GUS62 |
Study First Received: | October 20, 2006 |
Last Updated: | March 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00390975 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Tegaserod diabetes diabetic gastroparesis |
gastric emptying gastric retention electrogastrography |
Serotonin Agonists Neurotransmitter Agents Gastrointestinal Diseases Diabetes Mellitus Urinary Retention Serotonin Paralysis |
Signs and Symptoms Stomach Diseases Digestive System Diseases Neurologic Manifestations Tegaserod Gastroparesis |
Serotonin Agonists Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Gastrointestinal Diseases Physiological Effects of Drugs Pharmacologic Actions Paralysis |
Signs and Symptoms Stomach Diseases Digestive System Diseases Serotonin Agents Neurologic Manifestations Tegaserod Gastroparesis |